ASX:IMC
Immuron Limited
- Stock
locale
Australia
market
STOCKSindustry
Biotechnologywebsite
www.immuron.com.auipo date
Apr 30, 1999
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' di...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus